Skip to content Skip to footer
Subscribe Now
Exclusive_Kenneth-Sake_2025
EXCLUSIVE

Exclusive: Kenneth Sake from Blueprint Medicines in an Enlightening Conversation with PharmaShots

Highlights: Systemic mastocytosis (SM) is a rare disease caused by the abnormal accumulation of mast cells – a key part of the body’s immune systemPeople with SM face potentially debilitating symptoms, such as skin lesions, diarrhoea, bone pain, fatigue and anaphylaxis, which can present challenges across various aspects of patients’ livesFor more than…
March 12, 2025

Read more

Exclusive_Ahsan Arozullah_2024
EXCLUSIVE

Advancing Urothelial Carcinoma Care: Ahsan Arozullah from Astellas Pharma in an Exclusive Interview with PharmaShots

Shots: Recently, the CHMP of the EMA adopted a positive opinion for Astellas’ Padcev + Keytruda combination therapy as the first-line treatment of patients with unresectable or metastatic urothelial cancer Today, in an exclusive coverage, we bring an enlightening conversation with Ahsan Arozullah from Astellas Pharma, sharing insights from the P-III EV-302 study Astellas looks…
September 4, 2024

Read more

Exclusive_Anne Arnold_2023
EXCLUSIVE

Anne Arnold, Senior Director, Education & Training at Smile Train Shares Insights on New VR Platform for Pediatric Surgery

Shots: Anne started by talking about the launch of the first-ever cleft surgery virtual reality platform in collaboration with Biodigital, which simulates surgery on cleft lip and palate, a birth condition Anne explained how the VSS VR Extension technology enables surgeons worldwide to collaborate in virtual operating rooms, ensuring safer surgery and better outcomes for…
April 11, 2023

Read more

Exclusive_Iris Loew-Friedrich_2023
EXCLUSIVE

Iris Loew-Friedrich, CMO and Head of Development Solutions at UCB Shares her Thoughts on the Launch of New Innovators Campaign

Shots:Iris shared the specifics of the launch of the UCB’s Innovators campaign. The campaign spotlights the R&D employees’ perspectives on innovation and aims to highlight why innovation is a key driving force at UCB for bettering the lives of patientsShe gave her thoughts on how UCB is adopting innovative AI programs that use…
March 6, 2023

Read more

Exclusive_Stacey Williams_2023
EXCLUSIVE

Stacey Williams, Vice President, Marketing, Dermavant Shares Insights on New Campaigns for Adults with Plaque Psoriasis

Shots:Stacey talked about the launch of its first streaming commercial as part of a direct-to-consumer advertising campaign for adults with plaque psoriasisThe “Topical Uprising” campaign focuses on the patient journey and taps into the frustrations & self-conscious of living with plaque psoriasis that helps patients to demand more from their topical plaque psoriasis treatmentThe…
January 23, 2023

Read more

Exclusive_Nagesh Mahanthappa_2022
EXCLUSIVE

Nagesh Mahanthappa, Interim CEO of Scholar Rock Shares Insights on Treatment Options for Spinal Muscular Atrophy

Shots:Nagesh talked about how Spinal Muscular Atrophy (SMA) is affecting people all over the world and how Scholar Rock’s treatment options are improving the lives of those living with this diseaseNagesh also spoke about Scholar Rock’s lead product in SMA, apitegromab, highlighting its trial designs (TOPAZ & SAPPHIRE trials), outcomes, and real-world data…
October 3, 2022

Read more

Exclusive Interview_Philip M. Brown_Dr. Anna Tallman
EXCLUSIVE

Philip Brown & Anna Tallman of Dermavant Shares Insights on the Approval of its Topical Treatment for Plaque Psoriasis

Shots:Philip spoke about plaque psoriasis, symptoms, prognosis, and treatment options available. He also discussed different ongoing patient support programs by DermavantAnna talked about the approval of Dermavant’s lead topical treatment in plaque psoriasis, its clinical studies & resultsThe interview summarizes Dermavant’s aim to develop innovative therapeutics in immuno-dermatology to address the high…
August 1, 2022

Read more

Exclusive Interview_Shmulik Shapiro
EXCLUSIVE

Shmulik Shapiro, EVP of Business Development & Strategy at RSIP Vision Shares Insight on New AI Tool for Prostate MRI Analysis that Supports PI-RADS Scoring

Shots:Shmulik spoke about the key features and development of the new AI tool for Prostate MRI AnalysisShmulik emphasized the significance of this new tool in PI-RADS score and how this can be helpful in diagnosing prostate lesions in MRIThe interview provides a deeper understanding of medical imaging technologies that are emerging through…
July 25, 2022

Read more

Exclusive_Barbara Klencke_2022
EXCLUSIVE

Barbara Klencke, CMO at Sierra Oncology (now GSK) Shares Insights on the Significant benefits obtained from the Pivotal Myelofibrosis Study

Shots:Barbara gave a comprehensive view of the P-III (MOMENTUM) clinical study results which evaluates its lead candidate in myelofibrosisSierra is now acquired by GSK (completed on 1st July 2022) resulting in GSK commercializing this prime product once approvedThe interview outlines Sierra’s (now GSK) vision to develop transformative therapies for rare cancersSmriti: Thank…
July 18, 2022

Read more

Load more

Sign Up to Our Newsletter

Be the first to know the latest updates

[mc4wp_form id="13387" element_id="style-1"]